< Arab Finance - News - Arab Drug reports higher profit in FY 2020/2021
Count Down to relaunch



Arab Drug reports higher profit in FY 2020/2021

Arab Drug reports higher profit in FY 2020/2021

ArabFinance: The Arab Drug Company (ADCI) posted a net profit of EGP 102.063 million in the fiscal year (FY) 2020/2021, according to the company’s financial statements filed to the Egyptian Exchange.

This marked a Year on Year (YoY) rise of 110% when compared to EGP 92.800 million in FY 2019/2020.

In FY 2021/2022, ADCI is targeting a net profit of EGP 116.3 million and has allocated EGP 129.7 million for the year's investments.

Arab Drug is an Egypt-based company engaged in the pharmaceutical sector. The company focuses on the manufacture, packaging, and distribution of pharmaceutical products as well as chemical solutions for human and veterinary use.

#Related keywords

'

Recommended Stocks

11 Oct 2020
Tenth Of Ramadan Pharmaceutica... RMDA
Close
02.02
Change
-02.42
Buy

All rights reserved to Arab Finance 2020 ©

Back to top